Iodine supplies the raw material for the thyroid hormones that set the pace of metabolism and, in early life, brain development. Its safe range is narrow: correcting a real shortfall prevents an enlarged thyroid and supports normal thyroid function, while extra iodine beyond need offers little and can push the thyroid into over- or under-activity or trigger immune problems. (Full Review)

Protocol

Standard Dose

150 µg/day

~220–250 µg in pregnancy, 250–290 µg during lactation

Timing

Any time, with food

Taking with food reduces metallic taste and gastrointestinal upset

Frequency

Single daily dose

No established advantage to splitting at nutritional doses

Time to effect

Iodine Status

Days–weeks

Urinary iodine responds to intake

Thyroid Strain Markers

Weeks–months

Thyroid strain markers improve

Deficiency Symptoms

Weeks

Symptomatic benefits in deficiency unfold gradually

Benefits

High: Corrects deficiency and prevents goiter; supports thyroid hormone production and metabolic regulation

Medium: Offspring neurodevelopment with preconception and pregnancy repletion; relief of fibrocystic breast changes and cyclical breast pain

Low: Cognitive performance in marginally deficient individuals

Speculative: Anticancer and antioxidant effects of molecular iodine

Contraindications

Radioactive iodine therapy or thyroid scans (weeks before and during)

Autoimmune (Hashimoto's) thyroiditis

Graves' disease or a history of it

Nodular goiter or autonomous nodules

Existing hyperthyroidism

Prior thyroid surgery or radioiodine

Known iodine hypersensitivity

Key Interactions

Antithyroid drugs (methimazole, propylthiouracil)

Amiodarone

Lithium

Potassium-sparing diuretics (spironolactone, amiloride, triamterene), ACE inhibitors, ARBs

Selenium

Goitrogenic foods (raw cruciferous vegetables, soy)

Risk & Side Effects

High: Iodine-induced hyperthyroidism; iodine-induced hypothyroidism and goiter; precipitation or worsening of autoimmune thyroiditis

Medium: Acneiform skin eruptions

Low: Acute overdose and gastrointestinal irritation; iodine hypersensitivity and sialadenitis

Speculative: Association with papillary thyroid carcinoma at high intakes

Monitoring

Marker	Target	Why
TSH	~0.5–2.5 mIU/L	Primary signal of thyroid balance
Free T4	Mid-to-upper half of reference range	Directly reflects circulating thyroid hormone
Free T3	Mid-to-upper half of reference range	Reflects the biologically active hormone and tissue-level conversion
Anti-TPO antibodies	Negative / below assay cutoff	Flags autoimmune (Hashimoto's) thyroid disease
Thyroglobulin	Within reference range (not elevated)	A sensitive marker of iodine deficiency that falls as status is restored
Urinary iodine concentration	~100–299 µg/L	The standard measure of recent iodine intake and status
Selenium	Within adequate reference range	Adequate selenium protects the thyroid against iodine-induced injury

Cadence: Baseline before the first dose, then ~6–12 weeks after starting or changing dose, and every 6–12 months during continued use

Qualitative Assessment

Energy levels and freedom from unexplained fatigue
Stable body weight and normal tolerance of heat and cold
Absence of palpitations, tremor, anxiety, or insomnia (signs of over-activity)
Absence of new or growing neck swelling (goiter)
Normal mood, concentration, and cognitive clarity

Iodine for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment